RBC Capital Maintains Outperform on Spruce Biosciences, Lowers Price Target to $8
RBC Capital analyst Gregory Renza maintains Spruce Biosciences (NASDAQ:SPRB) with a Outperform and lowers the price target from $9 to $8.
Dow Jumps 700 Points; S&P 500 Rises Over 2%
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 700 points on Friday.
Nasdaq Gains 1.5%; Fate Therapeutics Shares Plunge
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 550 points on Friday.
Why Graphite Bio Shares Are Trading Lower By 50%; Here Are 20 Stocks Moving Premarket
Gainers
OncoCyte Corporation (NASDAQ: OCX) rose 89.2% to $0.70 in pre-market trading. Oncocyte, last month, announced an over 40% reduction of its workforce to realign the team towards key products that address larger markets.
Spruce Biosciences Shares Skyrocket After Licensing Pact For Lead Program
Spruce Biosciences Inc (NASDAQ:SPRB) and Kaken Pharmaceutical Co. Ltd entered into an exclusive licensing agreement for developing and commercializing Spruce’s tildacerfont for congenital…
Spruce Biosciences And Kaken Pharmaceutical Announce Exclusive Licensing Agreement To Develop And Commercialize Tildacerfont For CAH In Japan; Spruce To Receive $15M Upfront Payment Plus Milestones And Royalies
Partnership aims to accelerate global development and commercialization plans for tildacerfont to address worldwide unmet medical need in congenital adrenal hyperplasia (CAH)
Deal advances strategy to partner
Oppenheimer Maintains Outperform on Spruce Biosciences, Lowers Price Target to $8
Oppenheimer analyst Hartaj Singh maintains Spruce Biosciences (NASDAQ:SPRB) with a Outperform and lowers the price target from $13 to $8.
JMP Securities Initiates Coverage On Spruce Biosciences with Market Outperform Rating, Announces Price Target of $8
JMP Securities analyst Jonathan Wolleben initiates coverage on Spruce Biosciences (NASDAQ:SPRB) with a Market Outperform rating and announces Price Target of $8.
Stocks That Hit 52-Week Lows On Wednesday
During Wednesday's trading, 517 companies set new 52-week lows.